Yuksel T, Bozgeyik E, Bozgeyik I
Eurasian J Med. 2023; 55(3):204-207.
PMID: 37909191
PMC: 10724712.
DOI: 10.5152/eurasianjmed.2023.23073.
Bache M, Kadler F, Struck O, Medenwald D, Ostheimer C, Guttler A
Int J Mol Sci. 2023; 24(16).
PMID: 37629015
PMC: 10454434.
DOI: 10.3390/ijms241612835.
Han S, Tian Z, Tian H, Han H, Zhao J, Jiao Y
Cell Death Discov. 2023; 9(1):181.
PMID: 37301856
PMC: 10257651.
DOI: 10.1038/s41420-023-01476-0.
Yang J, Yang C, Li P
Open Med (Wars). 2023; 18(1):20220613.
PMID: 36694627
PMC: 9835196.
DOI: 10.1515/med-2022-0613.
Jasineviciute I, Hasan M, Grigas J, Pautienius A, Stankevicius A, Zymantiene J
Int J Mol Sci. 2023; 24(1).
PMID: 36614213
PMC: 9821218.
DOI: 10.3390/ijms24010770.
Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs.
Thomaidou A, Batsaki P, Adamaki M, Goulielmaki M, Baxevanis C, Zoumpourlis V
Int J Mol Sci. 2022; 23(15).
PMID: 35897831
PMC: 9367895.
DOI: 10.3390/ijms23158257.
MiRNAs in Lung Cancer: Diagnostic, Prognostic, and Therapeutic Potential.
Wani J, Majid S, Imtiyaz Z, Rehman M, Alsaffar R, Shah N
Diagnostics (Basel). 2022; 12(7).
PMID: 35885514
PMC: 9322918.
DOI: 10.3390/diagnostics12071610.
Long non-coding RNA DLX6-AS1 knockdown suppresses the tumorigenesis and progression of non-small cell lung cancer through microRNA-16-5p/BMI1 axis.
Wu C, Lin W, Fu F
Transl Cancer Res. 2022; 10(8):3772-3787.
PMID: 35116677
PMC: 8799293.
DOI: 10.21037/tcr-21-1240.
MicroRNA-16 Restores Sensitivity to Tyrosine Kinase Inhibitors and Outperforms MEK Inhibitors in -Mutated Non-Small Cell Lung Cancer.
Fanini F, Bandini E, Plousiou M, Carloni S, Wise P, Neviani P
Int J Mol Sci. 2021; 22(24).
PMID: 34948154
PMC: 8705178.
DOI: 10.3390/ijms222413357.
Aberrant Post-Transcriptional Regulation of Protein Expression in the Development of Chronic Obstructive Pulmonary Disease.
Aloufi N, Alluli A, Eidelman D, Baglole C
Int J Mol Sci. 2021; 22(21).
PMID: 34769392
PMC: 8584689.
DOI: 10.3390/ijms222111963.
Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells.
Yu Y, Tao M, Xu L, Cao L, Le B, An N
Cancer Biol Med. 2021; .
PMID: 34106558
PMC: 8832956.
DOI: 10.20892/j.issn.2095-3941.2020.0560.
miR-152/TNS1 axis inhibits non-small cell lung cancer progression through Akt/mTOR/RhoA pathway.
Duan J, Wang L, Shang L, Yang S, Wu H, Huang Y
Biosci Rep. 2020; 41(1).
PMID: 33269380
PMC: 7785040.
DOI: 10.1042/BSR20201539.
Targeting Epigenetics in Lung Cancer.
Chao Y, Pecot C
Cold Spring Harb Perspect Med. 2020; 11(6).
PMID: 32900703
PMC: 8168531.
DOI: 10.1101/cshperspect.a038000.
MicroRNA-95-3p inhibits cell proliferation and metastasis in colorectal carcinoma by HDGF.
Hong Y, Huang Z, Liu Q, E J, Gao X, Xin C
Biomed J. 2020; 43(2):163-173.
PMID: 32418767
PMC: 7283574.
DOI: 10.1016/j.bj.2019.03.006.
HDGF enhances VEGF‑dependent angiogenesis and FGF‑2 is a VEGF‑independent angiogenic factor in non‑small cell lung cancer.
Eguchi R, Wakabayashi I
Oncol Rep. 2020; 44(1):14-28.
PMID: 32319650
PMC: 7251661.
DOI: 10.3892/or.2020.7580.
6mer Seed Toxicity in Viral microRNAs.
Murmann A, Bartom E, Schipma M, Vilker J, Chen S, Peter M
iScience. 2019; 23(2):100737.
PMID: 31838022
PMC: 7033618.
DOI: 10.1016/j.isci.2019.11.031.
RGS4 Regulates Proliferation And Apoptosis Of NSCLC Cells Via microRNA-16 And Brain-Derived Neurotrophic Factor.
He Z, Yu L, Luo S, Li Q, Huang S, An Y
Onco Targets Ther. 2019; 12:8701-8714.
PMID: 31695428
PMC: 6821062.
DOI: 10.2147/OTT.S221657.
MicroRNA-152 suppresses cisplatin resistance in A549 cells.
Zhao W, Li H, Yang S, Guo D, Chen J, Miao S
Oncol Lett. 2019; 18(5):4613-4620.
PMID: 31611969
PMC: 6781694.
DOI: 10.3892/ol.2019.10834.
lncRNA TMEM51-AS1 and RUSC1-AS1 function as ceRNAs for induction of laryngeal squamous cell carcinoma and prediction of prognosis.
Hui L, Wang J, Zhang J, Long J
PeerJ. 2019; 7:e7456.
PMID: 31565549
PMC: 6743450.
DOI: 10.7717/peerj.7456.
miR-16 regulates proliferation and invasion of lung cancer cells via the ERK/MAPK signaling pathway by targeted inhibition of MAPK kinase 1 (MEK1).
Chen T, Xiao Q, Wang X, Wang Z, Hu J, Zhang Z
J Int Med Res. 2019; 47(10):5194-5204.
PMID: 31379227
PMC: 6833413.
DOI: 10.1177/0300060519856505.